Health Insurance Innovations (HIIQ) Upgraded at ValuEngine

Health Insurance Innovations (NASDAQ:HIIQ) was upgraded by research analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, February 14th.

Several other equities analysts also recently weighed in on the company. Zacks Investment Research upgraded Health Insurance Innovations from a “hold” rating to a “buy” rating and set a $26.00 target price on the stock in a research report on Wednesday, February 14th. B. Riley started coverage on Health Insurance Innovations in a report on Tuesday, February 13th. They set a “buy” rating and a $38.00 price target on the stock. BidaskClub cut Health Insurance Innovations from a “buy” rating to a “hold” rating in a report on Saturday, February 10th. Canaccord Genuity reissued a “buy” rating and set a $39.00 price target on shares of Health Insurance Innovations in a report on Friday, December 22nd. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $38.00 price target on shares of Health Insurance Innovations in a report on Tuesday, December 12th. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Health Insurance Innovations presently has an average rating of “Buy” and an average price target of $33.71.

Health Insurance Innovations (NASDAQ:HIIQ) traded down $1.65 during midday trading on Wednesday, reaching $29.15. The company had a trading volume of 220,900 shares, compared to its average volume of 390,616. The stock has a market capitalization of $481.39, a P/E ratio of 23.85 and a beta of 0.62. Health Insurance Innovations has a 12 month low of $12.65 and a 12 month high of $37.38.

In other news, Director Robert S. Murley bought 5,000 shares of Health Insurance Innovations stock in a transaction dated Friday, December 8th. The shares were purchased at an average cost of $22.50 per share, with a total value of $112,500.00. Following the completion of the acquisition, the director now owns 39,734 shares of the company’s stock, valued at approximately $894,015. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Sheldon Wang sold 10,000 shares of Health Insurance Innovations stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $25.20, for a total value of $252,000.00. Following the completion of the sale, the insider now directly owns 159,001 shares in the company, valued at $4,006,825.20. The disclosure for this sale can be found here. Insiders sold 92,464 shares of company stock worth $2,519,800 over the last ninety days. Insiders own 30.00% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Lyon Street Capital LLC increased its holdings in shares of Health Insurance Innovations by 55.2% in the fourth quarter. Lyon Street Capital LLC now owns 1,453,484 shares of the financial services provider’s stock worth $36,264,000 after purchasing an additional 516,737 shares during the last quarter. BlackRock Inc. increased its holdings in shares of Health Insurance Innovations by 0.5% in the fourth quarter. BlackRock Inc. now owns 823,596 shares of the financial services provider’s stock worth $20,548,000 after purchasing an additional 4,154 shares during the last quarter. CAS Investment Partners LLC bought a new stake in shares of Health Insurance Innovations in the fourth quarter worth about $18,717,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of Health Insurance Innovations by 131.3% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 668,208 shares of the financial services provider’s stock worth $16,672,000 after purchasing an additional 379,308 shares during the last quarter. Finally, Emerald Mutual Fund Advisers Trust increased its holdings in shares of Health Insurance Innovations by 3.1% in the third quarter. Emerald Mutual Fund Advisers Trust now owns 462,963 shares of the financial services provider’s stock worth $6,713,000 after purchasing an additional 14,008 shares during the last quarter. 64.05% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “Health Insurance Innovations (HIIQ) Upgraded at ValuEngine” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/23/valuengine-upgrades-health-insurance-innovations-hiiq-to-buy.html.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply